side effects of microdosing glp-1 Your guide to Microdosing GLP-1s: What You Should

Potential Demand for GLP-1s According to the Centers for Disease Control (CDC), in 2021, 29.4 million adults in the United States were diagnosed with diabetes (90 to 95 percent were T2D)

Additionally, the ability of GLP-1R agonists to modulate the NVU and reduce neuroinflammation suggests that they could slow the progression of neurodegenerative diseases

Increasing GLP-1 levels can be beneficial for managing type 2 diabetes and weight

5 They have also been shown to help patients avoid processed foods and snacks, with anecdotal data also suggesting reduced consumption of alcohol, drugs, and tobacco

Elevated 2-AG acts as a metabolic handbrake, calming hyperactive, stress-driven neural circuits in the brain

We look forward to offering guidance on these emerging brain benefits of GLP-1 medications